Physician profile
John Linz
NPI 1053316315
$11,842.57
in general payments reported to CMS, 2019-2025
23 companies · $1,274 in 2025
The $1,274 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $68.21 · 2021: $3,052 · 2022: $262 · 2023: $2,859 · 2024: $4,081 · 2025: $1,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,807 · Food and Beverage: $2,142 · Consulting Fee: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,807.47 |
| Food and Beverage | $2,142.03 |
| Consulting Fee | $265.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,384.59 | 2021-2025 | |
| Extremity Medical | $2,156.02 | 2024 | |
| Stryker Corporation | $1,733.33 | 2021-2025 | Pangea, Infinity Adaptis, Ortholoc 3di |
| Arthrex, INC. | $1,727.26 | 2023-2024 | |
| Legacy Ortho LLC | $1,171.63 | 2023-2024 | |
| Paragon 28, INC. | $359.59 | 2020-2024 | Additive Orthopedics, Ttc Nail |
| Next Science LLC | $265.53 | 2024 | Surgx, Blastx, Xperience |
| Wright Medical Technology, INC. | $219.16 | 2019 | |
| Becton, Dickinson and Company | $175.46 | 2023-2024 | Arista Ah Flexitip |
| Biotissue Holdings INC. | $124.65 | 2024 | |
| Smith+Nephew, INC. | $124.63 | 2019-2023 | Evos Mini |
| Pacira Pharmaceuticals Incorporated | $120.82 | 2024 | Exparel |
| Merck Sharp & Dohme LLC | $45.55 | 2024-2025 | Bridion |
| Medtronic, INC. | $42.13 | 2022-2025 | Inceptiv |
| Pacira Therapeutics, INC. | $40.88 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $29.76 | 2024 | Miami J |
| Kerecis Limited | $22.97 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Heron Therapeutics, INC. | $21.24 | 2022 | |
| Arteriocyte Medical Systems, INC. | $18.43 | 2025 | Magellan |
| Zimmer Biomet Holdings, INC. | $15.95 | 2022 | |
| Integra Lifesciences Corporation | $15.03 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $14.48 | 2025 | |
| Horizon Therapeutics Plc | $13.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Linz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.